NM_001378778.1:c.3407G>A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_001378778.1(MPDZ):​c.3407G>A​(p.Ser1136Asn) variant causes a missense change. The variant allele was found at a frequency of 0.00201 in 1,612,790 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Synonymous variant affecting the same amino acid position (i.e. S1136S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0021 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0020 ( 9 hom. )

Consequence

MPDZ
NM_001378778.1 missense

Scores

1
9
8

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: 4.70

Publications

9 publications found
Variant links:
Genes affected
MPDZ (HGNC:7208): (multiple PDZ domain crumbs cell polarity complex component) The protein encoded by this gene has multiple PDZ domains, which are hallmarks of protein-protein interactions. The encoded protein is known to interact with the HTR2C receptor and may cause it to clump at the cell surface. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2015]
MPDZ Gene-Disease associations (from GenCC):
  • hydrocephalus, nonsyndromic, autosomal recessive 2
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006310791).
BP6
Variant 9-13158063-C-T is Benign according to our data. Variant chr9-13158063-C-T is described in ClinVar as Benign. ClinVar VariationId is 740408.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00207 (315/152238) while in subpopulation NFE AF = 0.00184 (125/68016). AF 95% confidence interval is 0.00158. There are 1 homozygotes in GnomAd4. There are 199 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 9 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MPDZNM_001378778.1 linkc.3407G>A p.Ser1136Asn missense_variant Exon 24 of 47 ENST00000319217.12 NP_001365707.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MPDZENST00000319217.12 linkc.3407G>A p.Ser1136Asn missense_variant Exon 24 of 47 5 NM_001378778.1 ENSP00000320006.7 O75970-1

Frequencies

GnomAD3 genomes
AF:
0.00207
AC:
315
AN:
152120
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000507
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000656
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0149
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00184
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.00223
AC:
554
AN:
248442
AF XY:
0.00221
show subpopulations
Gnomad AFR exome
AF:
0.000388
Gnomad AMR exome
AF:
0.000320
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0121
Gnomad NFE exome
AF:
0.00231
Gnomad OTH exome
AF:
0.00282
GnomAD4 exome
AF:
0.00201
AC:
2934
AN:
1460552
Hom.:
9
Cov.:
30
AF XY:
0.00192
AC XY:
1397
AN XY:
726532
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33432
American (AMR)
AF:
0.000358
AC:
16
AN:
44656
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26102
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39564
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86200
European-Finnish (FIN)
AF:
0.0103
AC:
551
AN:
53352
Middle Eastern (MID)
AF:
0.000694
AC:
4
AN:
5762
European-Non Finnish (NFE)
AF:
0.00200
AC:
2219
AN:
1111182
Other (OTH)
AF:
0.00216
AC:
130
AN:
60302
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.445
Heterozygous variant carriers
0
155
311
466
622
777
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00207
AC:
315
AN:
152238
Hom.:
1
Cov.:
33
AF XY:
0.00267
AC XY:
199
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.000505
AC:
21
AN:
41566
American (AMR)
AF:
0.000655
AC:
10
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.0149
AC:
158
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00184
AC:
125
AN:
68016
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
17
35
52
70
87
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00165
Hom.:
0
Bravo
AF:
0.00114
TwinsUK
AF:
0.00270
AC:
10
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.00106
AC:
4
ESP6500EA
AF:
0.00182
AC:
15
ExAC
AF:
0.00229
AC:
276
Asia WGS
AF:
0.000289
AC:
1
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

MPDZ-related disorder Benign:1
Nov 06, 2023
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.36
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.37
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.064
T;.;.;.;.;.;.;.;.;T
Eigen
Uncertain
0.67
Eigen_PC
Pathogenic
0.70
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.96
D;D;D;D;D;D;.;D;D;D
MetaRNN
Benign
0.0063
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.84
T
MutationAssessor
Uncertain
2.3
M;M;M;.;.;M;M;.;.;.
PhyloP100
4.7
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-1.9
N;N;N;N;N;N;N;N;N;N
REVEL
Benign
0.22
Sift
Uncertain
0.0040
D;D;D;T;T;D;D;T;T;D
Sift4G
Uncertain
0.012
D;D;D;D;D;D;D;D;.;.
Polyphen
1.0, 0.99
.;D;D;.;D;.;D;.;.;.
Vest4
0.54
MVP
0.50
ClinPred
0.035
T
GERP RS
5.9
Varity_R
0.30
gMVP
0.47
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41265286; hg19: chr9-13158062; COSMIC: COSV105182814; API